In addition, the serological levels of MPO‐DNA were higher in patients with CRLM than that in patients with primary CRC and was positively correlated with serological FGF19 levels (Figure 6B; Figure S7B, Supporting Information). The gene discussed is FGF19; the disease is colorectal carcinoma.